Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luc Van Kaer

Showing results (1-10 of 239) with videos related to

Pageof 24
Sort By:
The Journal of Clinical Investigation|September 30, 2010
Comeback kids: CD8(+) suppressor T cells are back in the gameLuc Van Kaer
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Pillars article: antigen presentation: discovery of the peptide TAPLuc Van Kaer
Immunologic Research|October 13, 2004
Regulation of immune responses by CD1d-restricted natural killer T cellsLuc Van Kaer
Nature Reviews. Immunology|January 5, 2005
alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstaclesLuc Van Kaer
Current Opinion in Immunology|April 13, 2007
NKT cells: T lymphocytes with innate effector functionsLuc Van Kaer
Experimental Neurology|October 26, 2010
Glatiramer acetate for treatment of MS: regulatory B cells join the cast of playersLuc Van Kaer
European Journal of Immunology|May 28, 2015
Innate and virtual memory T cells in manLuc Van Kaer
Immunology and Cell Biology|June 10, 2004
Natural killer T cells as targets for immunotherapy of autoimmune diseasesLuc Van Kaer
Critical Reviews in Immunology|September 1, 2022
Preface: Unconventional T Cells in Health and DiseaseLuc Van Kaer
Expert Review of Clinical Immunology|May 19, 2010
Role of invariant natural killer T cells in immune regulation and as potential therapeutic targets in autoimmune diseaseLuc Van Kaer
Pageof 24

Showing results (1-10 of 239) with videos related to

Sort By:
Pageof 24
The Journal of Clinical Investigation|September 30, 2010
Comeback kids: CD8(+) suppressor T cells are back in the gameLuc Van Kaer
Journal of Immunology (Baltimore, Md. : 1950)|February 23, 2008
Pillars article: antigen presentation: discovery of the peptide TAPLuc Van Kaer
Immunologic Research|October 13, 2004
Regulation of immune responses by CD1d-restricted natural killer T cellsLuc Van Kaer
Nature Reviews. Immunology|January 5, 2005
alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstaclesLuc Van Kaer
Current Opinion in Immunology|April 13, 2007
NKT cells: T lymphocytes with innate effector functionsLuc Van Kaer
Experimental Neurology|October 26, 2010
Glatiramer acetate for treatment of MS: regulatory B cells join the cast of playersLuc Van Kaer
European Journal of Immunology|May 28, 2015
Innate and virtual memory T cells in manLuc Van Kaer
Immunology and Cell Biology|June 10, 2004
Natural killer T cells as targets for immunotherapy of autoimmune diseasesLuc Van Kaer
Critical Reviews in Immunology|September 1, 2022
Preface: Unconventional T Cells in Health and DiseaseLuc Van Kaer
Expert Review of Clinical Immunology|May 19, 2010
Role of invariant natural killer T cells in immune regulation and as potential therapeutic targets in autoimmune diseaseLuc Van Kaer
Pageof 24